Evidence map›Paper›PMID 40024982›Full record

ArticlePurinergic signalling2025

Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse line.

Iven-Alex von Mücke-Heim, Judit Oldekamp, Michael W Metzger, Sarah Kläffgen, Hao Tang, Sandra M Walser, Nina Dedic, Gerhard Rammes, Florian Holsboer, Wolfgang Wurst and 1 more

Abstract read
In one paragraph

Article in Purinergic signalling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iven-Alex von Mücke-HeimMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.ORCID 0000-0002-5021-9495
Judit OldekampMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
Michael W MetzgerMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
Sarah KläffgenMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
Hao TangMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
Sandra M WalserMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
Nina DedicMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
Gerhard RammesDepartment of Anesthesiology and Intensive Care, Klinikum Rechts Der Isar, 81675, Munich, Germany.
Florian HolsboerMax Planck Institute of Psychiatry, Present Address: HMNC Brain Health, 80539, Munich, Germany.ORCID 0000-0002-2640-9336
Wolfgang WurstInstitute of Developmental Genetics, Helmholtz Zentrum München, 85764, Neuherberg, Germany.ORCID 0000-0003-4422-7410
Jan M DeussingMolecular Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany. deussing@psych.mpg.de.ORCID 0000-0002-9329-5252

Funding

German Federal Ministry of Education and Research 01GS08151
6 · The paper itself

Abstract

The P2X7 receptor is an adenosine triphosphate (ATP)-gated ion channel expressed in different cell types of the brain. Polymorphisms in the P2RX7 gene have repeatedly been associated with psychiatric disorders including major depression. Depression is a stress-related disorder in which a dysregulation of the immune system has attracted increasing attention as a potential disease mechanism. The well-documented role of P2X7 in inflammatory conditions advocates its involvement in immune system dysregulation and depression genesis. However, understanding its exact role requires further research using appropriate animal models. Unfortunately, some of the most widely used P2X7 knockout mouse models are limited in their utility by the continuous expression of certain P2rx7 splice variants or even activation of de novo transcripts. To overcome this limitation, we generated a novel constitutive and complete P2X7 KO mouse line. These KO mice lack all known murine splice variants and protein expression resulting in a loss-of-function as confirmed by calcium imaging and by the inability of P2X7-deficient peritoneal macrophages to mount an appropriate interleukin (IL)-1β response. Comprehensive characterization using a battery of tests assessing locomotion, anxiety- and depression-related as well as social behaviour revealed differences in locomotor and exploratory behaviours. P2X7 KO mice showed slightly increased locomotor activity and reduced anxiety-related behaviour at baseline. Under conditions of chronic stress exposure, genotype-dependent differences largely dissolved while P2X7 deficiency promoted enhanced stress resilience with regard to social behaviour. Taken together, our findings add further evidence for an involvement of the P2X7 in shaping different behavioural responses and their modulation by stressful environments. This novel loss-of-function model will contribute to a better understanding of P2X7 in stress-associated behaviours in basic and translational neuropsychiatric research.

Indexed as

Behavior, AnimalReceptors, Purinergic P2X7AnimalsAnxietyDepressionDisease Models, AnimalMaleMiceMice, Inbred C57BLMice, KnockoutStress, PsychologicalP2rx7 protein, mouseReceptors, Purinergic P2X7BehaviourKnockout miceP2rx7 geneP2X7 receptorPurinergic

Identifiers

PMID40024982
PMCPMC12595207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.